We set out to investigate on KDM5C expression and H3K4me3 levels in Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) obtained from eight NDD patients (P) with mutations in KDM5C or in its three regulators (Table 1). This evidence concerns the gene KDM5C and Neurodevelopmental delay.